Literature DB >> 19653083

Hexa-thiocarbamoyl phenyl PEG5K Hb: vasoactivity and structure: influence of rigidity of the conjugation linkage on the PEGylation induced plasma expander-like solution properties of PEG-Hb adducts.

Fantao Meng1, Belur N Manjula, Amy G Tsai, Pedro Cabrales, Marcos Intaglietta, Paul K Smith, Muthuchidambaram Prabhakaran, Seetharama A Acharya.   

Abstract

A new hexaPEGylated hemoglobin, (TCP-PEG5K)(6)-Hb (TCP, thiocarbamoyl phenyl) has been developed using PEG-phenyl-isothiocyanate and its vasoactivity and structure has been investigated. Of the six PEG5K chains of (TCP-PEG5K)(6)-Hb, 4 are conjugated to the alpha-amino groups of Hb, and the other 2 chains are distributed on epsilon-amino groups, identified as Lys-40(alpha) (approximately 45%), Lys-56(alpha) (approximately 25%), and Lys-8(beta) (approximately 24%). The studies with hamster infused with a bolus of a 4 gm % solution of (TCP-PEG5K)(6)-Hb equivalent to 10% of their blood volume have established that this new hexaPEGylated Hb is vasoinactive. The viscosity and the colloidal osmotic pressure of (TCP-PEG5K)(6)-Hb at 4% is 1.9 cP and 69.7 mmHg, respectively. The molecular radius of (TCP-PEG5K)(6)-Hb is about 4.6 nm and is significantly smaller than hexaPEGylated Hbs developed using other direct and extension arm facilitated PEGylation platform. The presence of an outside the central cavity intramolecular crosslink, succinimidophenyl-PEG2K between Cys-93(beta, beta') in (TCP-PEG5K)(6)-betabeta-Hb strongly impacts its solution properties. These patterns of influence suggest that the inter-dimeric interactions in (TCP-PEG5K)(6)-Hb is weakened just as with other direct PEGylation platforms, and (SP-PEG5K)(6)-Hb generated by EAF-PEGylation is unique in not inducing this effect. A comparison of the properties of hexaPEGylated Hbs establishes that rigidity of the conjugation linkage between PEG and Hb plays a significant influence on the resultant dictating solution properties and/structure/conformation of PEG-Hb adduct.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653083     DOI: 10.1007/s10930-009-9185-0

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  35 in total

Review 1.  Oxygen carriers ("blood substitutes")--raison d'etre, chemistry, and some physiology.

Authors:  J G Riess
Journal:  Chem Rev       Date:  2001-09       Impact factor: 60.622

2.  Purification and molecular analysis of hemoglobin by high-performance liquid chromatography.

Authors:  Belur N Manjula; Seetharama A Acharya
Journal:  Methods Mol Med       Date:  2003

3.  Influence of the chemistry of conjugation of poly(ethylene glycol) to Hb on the oxygen-binding and solution properties of the PEG-Hb conjugate.

Authors:  Tao Hu; Muthuchidambaram Prabhakaran; Seetharama A Acharya; Belur N Manjula
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

4.  Allosteric effectors influence the tetramer stability of both R- and T-states of hemoglobin A.

Authors:  Gusztáv Schay; László Smeller; Antonio Tsuneshige; Takashi Yonetani; Judit Fidy
Journal:  J Biol Chem       Date:  2006-07-05       Impact factor: 5.157

5.  Isolation and characterization of a new hemoglobin derivative cross-linked between the alpha chains (lysine 99 alpha 1----lysine 99 alpha 2).

Authors:  R Chatterjee; E V Welty; R Y Walder; S L Pruitt; P H Rogers; A Arnone; J A Walder
Journal:  J Biol Chem       Date:  1986-07-25       Impact factor: 5.157

6.  Non-conservative surface decoration of hemoglobin: influence of neutralization of positive charges at PEGylation sites on molecular and functional properties of PEGylated hemoglobin.

Authors:  Dongxia Li; Tao Hu; Belur N Manjula; Seetharama A Acharya
Journal:  Biochim Biophys Acta       Date:  2008-04-11

7.  Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide.

Authors:  R J Rohlfs; E Bruner; A Chiu; A Gonzales; M L Gonzales; D Magde; M D Magde; K D Vandegriff; R M Winslow
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

8.  Intrinsic fluorescence emission of intact oxy hemoglobins.

Authors:  R E Hirsch; R S Zukin; R L Nagel
Journal:  Biochem Biophys Res Commun       Date:  1980-03-28       Impact factor: 3.575

9.  Microvascular PO2 during extreme hemodilution with hemoglobin site specifically PEGylated at Cys-93(beta) in hamster window chamber.

Authors:  Pedro Cabrales; Nirmala Devi Kanika; Belur N Manjula; Amy G Tsai; Seetharama A Acharya; Marcos Intaglietta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-06-10       Impact factor: 4.733

Review 10.  Cell-free oxygen carriers: scientific foundations, clinical development, and new directions.

Authors:  Robert M Winslow
Journal:  Biochim Biophys Acta       Date:  2008-05-21
View more
  4 in total

1.  Determination of extinction coefficients of human hemoglobin in various redox states.

Authors:  Fantao Meng; Abdu I Alayash
Journal:  Anal Biochem       Date:  2017-01-06       Impact factor: 3.365

2.  Tissue oxidative metabolism after extreme hemodilution with PEG-conjugated hemoglobin.

Authors:  Pedro Cabrales; Fantao Meng; Seetharama A Acharya
Journal:  J Appl Physiol (1985)       Date:  2010-09-02

3.  PEGylation of αα-Hb using succinimidyl propionic acid PEG 5K: Conjugation chemistry and PEG shell structure dictate respectively the oxygen affinity and resuscitation fluid like properties of PEG αα-Hbs.

Authors:  Fantao Meng; Amy G Tsai; Marcos Intaglietta; Seetharama A Acharya
Journal:  Artif Cells Nanomed Biotechnol       Date:  2014-03-06       Impact factor: 5.678

Review 4.  Molecular Simulations of PEGylated Biomolecules, Liposomes, and Nanoparticles for Drug Delivery Applications.

Authors:  Hwankyu Lee
Journal:  Pharmaceutics       Date:  2020-06-10       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.